SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Iamarangerboy who wrote (9757)10/23/2006 8:03:22 PM
From: Robohogs  Respond to of 10280
 
Fall off today is Somaxon Silenor results and worries about Xopenex nebulizer CMS pricing which was supposed to come out by October 14 if it was going to impact January price levels. Sepracor has now indicated to some that it will abandon the Medicare mkt (upward to 20-25% of Xop neb revenues) if a good compromise cannot be reached. This will protect Medicaid pricing which is based on lowest price.

Jon